Mobility · Research catalogMobility research material
TB-500 research peptide
TB-500 is a synthetic fragment associated with thymosin beta-4 research. The compound appears in laboratory discussions of cell migration, tissue organization, wound models, and angiogenesis-related biology. Its research identity is distinct from a consumer product claim: the literature describes experimental systems, while the catalog supplies a defined research material. This page brings the existing product record, research guide, and documentation status together in one place.
Catalog price
Size
5mg · 10 vials
- Availability
- Listed — documentation connected
- Testing status
- CoA available
- Lot / batch
- DEMO-TB500-A
- Documentation
- View Certificate of Analysis
Shipping information is shown in checkout before payment. For laboratory research use only. Not for human or veterinary consumption.
Documentation status
Certificate of analysis
Independent analytical testing record for TB-500, including HPLC purity, LC-MS identity, and visual examination. Review the complete document for method scope and reported results.
Review method coverage, batch identity, and reported analytical results.
Research involving TB-500
The repository’s TB-500 guide describes the compound in relation to the actin-binding region of thymosin beta-4. Research interest commonly centers on how that region relates to cell movement and tissue-level processes in experimental models.
The cited material includes wound-healing and cell-migration research, along with discussion of vascular and connective-tissue biology. These are areas of investigation rather than assurances of efficacy, and the page intentionally avoids translating them into human or veterinary use claims.
The catalog lists TB-500 as lyophilized powder in 5 mg · 10-vial packaging. No source-linked laboratory report is connected to this product record yet. Synthetic interface references are clearly labelled and are not testing evidence.
Quality and testing
Lot-specific analytical documentation is attached to this product record. The report covers chromatographic purity, identity, visual examination, with additional tests listed in the document.
TB-500 specifications
| Form | Lyophilized powder |
| Amount | 5 mg · 10 vials |
| Catalog category | Mobility |
| Intended use | Laboratory research only |
Storage and handling
Unopened lyophilized material should be stored refrigerated at 2–8°C. For long-term storage, maintain at −20°C. Protect from light. Reconstituted solutions should be used promptly or aliquoted and frozen at −20°C. Avoid repeated freeze-thaw cycles.
For laboratory research use only. Not for human or veterinary consumption. Handle in accordance with institutional safety protocols.
How TB-500 is studied
TB-500 appears in the repository through wound, cell-migration, and tissue-biology literature. Research discussions may compare cellular movement, structural organization, and vascular markers across experimental models. No administration, dose, cycling, or reconstitution protocol is provided here.
TB-500 FAQs
What is TB-500?
TB-500 is a synthetic fragment associated with thymosin beta-4 research and is discussed in relation to cell migration and tissue biology.
What research areas include TB-500?
The site’s research guide covers cell migration, wound-model research, angiogenesis-related biology, and the actin-binding region of thymosin beta-4.
Is a TB-500 COA available?
Not yet. A source-linked Certificate of Analysis is not connected in the current catalog. Synthetic interface references are clearly labelled and are not testing evidence.
What quantity is listed for TB-500?
The current catalog lists 5 mg · 10 vials.
Is TB-500 for human or veterinary use?
No. It is presented for laboratory research only and is not for human or veterinary consumption.